Related references
Note: Only part of the references are listed.Cerebrovascular disease in ageing and Alzheimer's disease
Seth Love et al.
ACTA NEUROPATHOLOGICA (2016)
Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme
Kate M. Larmuth et al.
FEBS JOURNAL (2016)
Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-beta (A beta) Plaque Load and A beta-Synthesizing and A beta-Degrading Enzymes in Frontal Cortex
Emma L. Ashby et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease?
Yuri V. Mezentsev et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)
MCPB.py: A Python Based Metal Center Parameter Builder
Pengfei Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease
Sergey A. Kozin et al.
MENDELEEV COMMUNICATIONS (2016)
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice
Alexandra A. Kulikova et al.
NEUROTOXICITY RESEARCH (2016)
Interplay of histidine residues of the Alzheimer's disease Aβ peptide governs its Zn-induced oligomerization
Andrey N. Istrate et al.
SCIENTIFIC REPORTS (2016)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies
Jessica Nasica-Labouze et al.
CHEMICAL REVIEWS (2015)
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Erik S. Musiek et al.
NATURE NEUROSCIENCE (2015)
Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease
Ronan O'Caoimh et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer's Disease
Said AbdAlla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis
Natacha Levi Marpillat et al.
JOURNAL OF HYPERTENSION (2013)
Catalytic Mechanism of Angiotensin-Converting Enzyme and Effects of the Chloride Ion
Chunchun Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
ESI-MS Identification of the Minimal Zinc-Binding Center in Natural Isoforms of β-Amyloid Domain 1-16
I. A. Popov et al.
MOLECULAR BIOLOGY (2013)
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker et al.
NATURE (2013)
Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis
S. A. Kozin et al.
NEUROTOXICITY RESEARCH (2013)
Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide
Rebecca M. Nisbet et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2013)
Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia
Yang Gao et al.
BMJ OPEN (2013)
NMR Solution Structure of Rat Aβ(1-16): Toward Understanding the Mechanism of Rats' Resistance to Alzheimer's Disease
Andrey N. Istrate et al.
BIOPHYSICAL JOURNAL (2012)
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?
Natalia N. Nalivaeva et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
Geoffrey Masuyer et al.
SCIENTIFIC REPORTS (2012)
Capabilities of MS for Analytical Quantitative Determination of the Ratio of α- and βAsp7 Isoforms of the Amyloid-β Peptide in Binary Mixtures
Maria I. Indeykina et al.
ANALYTICAL CHEMISTRY (2011)
The Association Between Blood Pressure and Incident Alzheimer Disease A Systematic Review and Meta-analysis
Melinda C. Power et al.
EPIDEMIOLOGY (2011)
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
Yi-Fei Dong et al.
FASEB JOURNAL (2011)
Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias
Neil M. Davies et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Inhibitor and Substrate Binding by Angiotensin-Converting Enzyme: Quantum Mechanical/Molecular Mechanical Molecular Dynamics Studies
Xuemei Wang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Vascular risk factor detection and control may prevent Alzheimer's disease
Jack C. de la Torre
AGEING RESEARCH REVIEWS (2010)
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
Koji Yamada et al.
BRAIN RESEARCH (2010)
Structural Survey of Zinc-Containing Proteins and Development of the Zinc AMBER Force Field (ZAFF)
Martin B. Peters et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases
Kurt A. Jellinger
NEURODEGENERATIVE DISEASES (2010)
Vascular basis for brain degeneration: faltering controls and risk factors for dementia
Raj N. Kalaria
NUTRITION REVIEWS (2010)
Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states
Yifat Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: An observational study
Ihab M. Hajjar et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2008)
Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-β peptides
Xiaoou Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy
J. S. Miners et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's A beta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Ilya Yu. Toropygin et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme
Elizabeth A. Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host
Melanie Meyer-Luehmann et al.
SCIENCE (2006)
Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design
HR Corradi et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Structural changes of region 1-16 of the Alzheimer disease amyloid β-peptide upon zinc binding and in vitro aging
S Zirah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Update on hypertension and Alzheimer's disease
Ingmar Skoog et al.
NEUROLOGICAL RESEARCH (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
3D structure of Alzheimer's amyloid-β(1-42) fibrils
T Lührs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease
DJ Lehmann et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide
R Oba et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Absolute quantitation of proteins by a combination of acid hydrolysis and matrix-assisted laser desorption/ionization mass spectrometry
OA Mirgorodskaya et al.
ANALYTICAL CHEMISTRY (2004)
Drug therapy - Alzheimer's disease
JL Cummings
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Structure of angiotensin I-converting enzyme
ED Sturrock et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
ACE revisited: A new target for structure-based drug design
KR Acharya et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
The renin-angiotensin and the kallikrein-kinin systems
DJ Campbell
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Crystal structure of the human angiotensin-converting enzyme-lisinopril complex
R Natesh et al.
NATURE (2003)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Share Paper
